Operating now
North Miami Beach
100 NW 170 St, Suite 305North Miami Beach, FL 33169
Legal address of Amavita Research, clinical trial site and heart practice.
For Sponsors and CROs
The GCSA-certified Miami cardiovascular clinical trial site
GCSA-certified Miami cardiovascular clinical trial site. Heart failure, hypertension and peripheral artery disease studies, with a senior principal investigator and interventional cardiologist with a structural-heart (TAVR) research background, a South Florida heart practice and a dedicated cardiovascular ASC.
Senior PI is Dr. William W. O'Neill, senior principal investigator and interventional cardiologist with a structural-heart (TAVR) research background and PROTECT II national PI, PROTECT IV Steering Committee member, and PARTNER site PI at Henry Ford. Dr. Pedro Martinez-Clark is a principal investigator. GCSA-certified (Feb 2025). ICH-GCP E6(R3) compliant. Dedicated cardiovascular ASC at 9408 SW 87th Ave, Suite 303, Miami, FL 33176.
Trusted by Alnylam / Pfizer / Pharmacosmos / JK07 Bio / Vasa / 14 more.
Two operating locations: the North Miami Beach clinical trial site and heart practice, plus the Kendall cardiovascular surgery center. see locations.
See full trial services →See site capabilities →
Are you a referring physician? See our physician info →
A cardiovascular site that also runs Phase 1: Phase 1 studies in an ASC setting at our affiliated Advanced Cardiovascular of Miami. Learn more →
Cardiovascular research is our core. Immunology, oncology, and neurology are expansion areas through imaging-enabled subcontracted scopes, with Amavita as prime contractor and our affiliated imaging partner performing imaging. Our own site trials are cardiovascular-led. We are now recruiting partner practices in oncology, neurology, immunology, gastroenterology, rheumatology and other areas. Oncology expansion · Neurology expansion · Cardiac PET support · Trial-site capabilities
Indication hubs
Public cardiovascular indication pages
New-sponsor first-touch, CDA, and NDA go to Julio G. Martinez-Clark, julio@amavita.health. Julio signs CDAs.
Locations
Two operating locations
North Miami Beach, FL 33169
Operating now
Kendall
9408 SW 87th Ave, Suite 303Miami, FL 33176
Cardiovascular surgery center.
Cardiac PET Study SupportPhase 1 Healthy Volunteers
Cardiac PET Study Support
Amavita Research provides the cardiovascular trial site for recruitment, screening, investigator oversight, and visit conduct. Cardiac PET studies are supported through our affiliated imaging partner.
Cardiac PET support
Protocol-required cardiac PET imaging is performed by our affiliated imaging partner.
Trial-site services
Recruitment, screening, investigator oversight, visit conduct, and standard safety assessments.
Imaging responsibility
The affiliated imaging partner performs cardiac PET imaging and manages its imaging-specific requirements.
GCSA-certified site
Cardiology principal investigators and diverse Miami enrollment.
Cardiac PET clinical trials in Miami · Cardiac PET study support
Integrated Americas ModelFIH → Expansion
First-in-human in Latin America. Expansion in Miami. One team.
Amavita Research's sister organization bioaccess® is a first-in-human CRO operating across the Americas — 50+ delivered FIH programs since 2010. Together, we give sponsors an integrated path: run your first-in-human or Phase 1 cohort in Latin America, then expand at our GCSA-certified Miami site — coordinated through a single team and a single BD contact.
FIH where it moves fastest.
bioaccess® runs first-in-human and Phase 1 programs across Latin America, with 15+ years of operating experience in the region.
Expansion where it counts.
Amavita Research's Miami site — GCSA-certified, led by the senior principal investigator and interventional cardiologist with a structural-heart (TAVR) research background, with a diverse enrollment population — takes your US expansion cohorts.
One team, one process.
Feasibility, contracting, and study management coordinated across both. You don't manage two vendors.
Built-in patient flowPatient access through our affiliated cardiovascular practiceindependent Miami cardiovascular practice; 16,000+ patients seen in the last 3 years
Powered by amavita Heart and Vascular Health® — an independent Miami cardiovascular practice; 16,000+ patients seen in the last 3 years
Sponsors get enrollment from a continuously-recruiting cardiology practice with a high cardiovascular patient volume — not a CRO sourcing from referral networks. Our PIs see trial-eligible patients in clinic every day, screen them in real time, and convert them in the same building.
amavita Heart and Vascular Health® is an independent Miami cardiovascular practice; 16,000+ patients seen in the last 3 years. Patients are seen in-house through our affiliated cardiovascular practice.
In-house
Continuous CV patient pipeline from the parent practice
No referrals
Eliminates the slow, costly CRO referral-network bottleneck
Same building
Trial conversion happens at the point of cardiology care
IAOCR GCSA CertifiedICH-GCP E6 (R3)SCRS Member
Why Amavita
Six reasons sponsors choose Amavita Research as their Miami site partner.
IAOCR GCSA-certified (Feb 2025)
Sponsor audit prep, condensed. GCSA is an ISO-style site accreditation in clinical research. Amavita Research is GCSA-certified (Feb 2025). Your monitor does not have to verify what an independent body has already certified. See /certifications for full scope.
ICH-GCP E6 (R3) Compliant
Already operating to E6(R3). When your protocol crosses a regulator's desk, our quality systems are not a question -- they are a footnote.
Blue-Chip Track Record
Trusted by 19 sponsors including Alnylam, Pfizer, Pharmacosmos, and JK07 Bio. The same sponsors keep coming back for their second and third study with us -- that is the data point that matters.
Two operating locations
The legal address, clinical trial site and heart practice are at 100 NW 170 St, Suite 305, North Miami Beach, FL 33169. The operating cardiovascular ASC is at 9408 SW 87th Ave, Suite 303, Miami, FL 33176.
Diverse Miami Population
Hispanic, Haitian, and Caribbean recruitment baked in. With FDA Diversity Action Plans now mandatory for Phase 3 cardiovascular trials, our zip code is a diverse Miami patient population -- not a marketing line.
New-sponsor first-touch
New-sponsor first-touch, CDA, and NDA go to Julio G. Martinez-Clark, CEO, Amavita Research Services, LLC, julio@amavita.health or 786-703-5941. Julio signs CDAs. Dr. Pedro Martinez-Clark is a principal investigator only. Sponsor inquiries: julio@amavita.health or 786-703-5941. After award, Nereisy Alonso (COO) leads study operations.
Investigator ExcellenceFDA-Pivotal Device Trials
A Senior PI with a track record of FDA-pivotal device trial leadership
Our Senior Principal Investigator Dr. William W. O'Neill, MD, FACC has served as National Principal Investigator (chair) of PROTECT II, a Steering Committee member for PROTECT IV, and Principal Investigator at Henry Ford for the PARTNER trial — a track record of FDA-pivotal device trial leadership matched by few investigators in the United States.
Affiliated ASC · Strategic Differentiator
An affiliated cardiovascular ambulatory surgery center in Miami
Sponsors partnering with Amavita Research have access to the affiliated Advanced Cardiovascular of Miami, a dedicated cardiovascular ambulatory surgery center in Miami with cath lab access for same-day procedures, subject to protocol feasibility.
3D ImagingCardiac Mapping SystemCatheterization LabsMinimally Invasive Interventional SuitesOne-Stop Diagnosis-to-Intervention Workflow
Visit the surgery center site ASC Capabilities
Procedures supported on-site
Complex device, structural-heart, and interventional studies executed in a controlled outpatient setting — reducing hospital-based variability.
Cardiology
- Cardiac Catheterization
- Cardiac Mapping & Ablation
- Coronary Intervention
- Implantable Cardiac Monitors
- Pacemakers / ICDs / Bi-Ventricular Devices
- Peripheral Artery & Vein Angiography & Intervention
Interventional Radiology
- Dialysis Access Management
- Genicular / Hemorrhoidal / Prostate Artery Embolization
- Kyphoplasty
- Spinal Cord Stimulator Implantation
- Uterine Fibroid Embolization
Technology
3D ImagingCardiac Mapping SystemCatheterization LabsMinimally Invasive Interventional SuitesOne-Stop Diagnosis-to-Intervention Workflow
Capabilities that move your study forward
From feasibility through close-out, our team operates as a true extension of yours — bringing deep cardiometabolic experience and the infrastructure to execute complex protocols.
Therapeutic Expertise
Deep experience across cardiology, heart failure (HFrEF/HFpEF), hypertension, ACS, vascular and metabolic studies — Phase 1 through Phase 3.
Modern Recruitment Technology
EHR-integrated patient identification, predictive screening, and a digital pre-screening funnel that accelerates enrollment.
Trained, Bilingual Staff
Board-certified PI, study coordinators, and regulatory specialists fluent in English, Spanish, and Haitian Creole — matching South Florida's patient population.
Miami-Area Patient Diversity
Access to one of the most ethnically and clinically diverse patient populations in the United States.
Trusted by leading sponsors
- Pfizer
- Alnylam Pharmaceuticals
- Pharmacosmos
- Avantec / Nipro
- Vasa Therapeutics
- Impulse Dynamics
- Novo Nordisk
- Salubris / JK07 Bio
- AnaCardio
- Janssen
- Cardurion Pharmaceuticals
- River 2 Renal
- Cordio Medical
- GE Healthcare
- AngioDynamics
- Revive Therapeutics
- Vifor / Relypsa
- ImpediMed
- Boehringer Ingelheim
Pharmaceutical, biotech, and device partners across active and completed trials
Our approach
How we run a study
Start-up timelines depend on the protocol, the sponsor's contracting process and the IRB of record, and we estimate them per study during feasibility.
Per-protocol enrollment, screen-fail rate, and timeline data available under mutual CDA.
New-sponsor first-touch
Julio G. Martinez-Clark
CEO, Amavita Research Services, LLC
New-sponsor first-touch, CDA, and NDA. Julio signs CDAs. Dr. Pedro Martinez-Clark is a principal investigator only.
Contact our sponsor teamStudy operations after award
Nereisy Alonso, Sr CRC, COO
Sponsor inquiries: julio@amavita.health or 786-703-5941. After award, Nereisy Alonso (COO) leads study operations.
Questions about how we work?
14 direct answers on PIs, timelines, capacity, certifications, cost, data ownership, and more.
FAQ
Frequently Asked Questions
Quick answers about our certifications, leadership, and sponsor partnerships.